BioAmber Inc. Financing Cash Flow
BioAmber Inc. reported Financing Cash Flow of $8.12 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2014-05-13
- BioAmber Inc. net cash provided by (used in) financing activities for the quarter ending 2014-03-31 was $8.12M, a 883.01% increase year-over-year.
- BioAmber Inc. net cash provided by (used in) financing activities for the quarter ending 2013-12-31 was $2.96M, a 38.98% decline year-over-year.
- BioAmber Inc. net cash provided by (used in) financing activities for the quarter ending 2013-09-30 was $68.37K, a 97.29% decline year-over-year.
- BioAmber Inc. net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was $96.07M.
- BioAmber Inc. net cash provided by (used in) financing activities for fiscal 2013 was $99.92M, a 499.36% increase from fiscal 2012.
- BioAmber Inc. net cash provided by (used in) financing activities for fiscal 2012 was $16.67M, a 75.05% decline from fiscal 2011.
- BioAmber Inc. net cash provided by (used in) financing activities for fiscal 2011 was $66.81M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 53 month | Net Cash Provided by (Used in) Financing Activities 56 month | Net Cash Provided by (Used in) Financing Activities 59 month | Net Cash Provided by (Used in) Financing Activities 62 month | Net Cash Provided by (Used in) Financing Activities 65 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $8.12M 10-Q · filed 2014-05-13 | $11.08M derived: sum of 2 quarters · filed 2014-05-13 | $11.15M derived: sum of 3 quarters · filed 2014-05-13 | $107.22M derived: sum of 4 quarters · filed 2014-05-13 | $204.86M 10-Q · filed 2014-05-13 | ||||
| 2013-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.03M derived: sum of 2 quarters · filed 2014-03-28 | $99.10M derived: sum of 3 quarters · filed 2014-03-28 | $99.92M 10-K · filed 2014-03-28 | $196.74M 10-K · filed 2014-03-28 | ||||
| 2013-09-30 | $68.37K 10-Q · filed 2013-11-13 | $96.14M derived: sum of 2 quarters · filed 2013-11-13 | $96.96M 10-Q · filed 2013-11-13 | $101.81M derived: sum of 4 quarters · filed 2014-05-13 | $193.78M 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | $96.07M 10-Q · filed 2013-08-14 | $96.90M 10-Q · filed 2013-08-14 | $101.75M derived: sum of 3 quarters · filed 2014-05-13 | $104.27M derived: sum of 4 quarters · filed 2014-05-13 | $193.71M 10-Q · filed 2013-08-14 | ||||
| 2013-03-31 | $826.49K 10-Q · filed 2014-05-13 | $5.68M derived: sum of 2 quarters · filed 2014-05-13 | $8.20M derived: sum of 3 quarters · filed 2014-05-13 | $7.55M derived: sum of 4 quarters · filed 2014-05-13 | $97.78M 10-Q/A · filed 2013-06-10 | ||||
| 2012-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $7.37M derived: sum of 2 quarters · filed 2014-03-28 | $6.73M derived: sum of 3 quarters · filed 2014-03-28 | $16.67M 10-K · filed 2014-03-28 | |||||
| 2012-09-30 | $2.52M 10-Q · filed 2013-11-13 | $1.88M derived: sum of 2 quarters · filed 2013-11-13 | $11.82M 10-Q · filed 2013-11-13 | ||||||
| 2012-06-30 | -$648.12K 10-Q · filed 2013-08-14 | $9.30M 10-Q · filed 2013-08-14 | |||||||
| 2012-03-31 | $9.95M 10-Q/A · filed 2013-06-10 | ||||||||
| 2011-12-31 | $66.81M 10-K · filed 2014-03-28 |